ReOx
ReOx is a drug discovery company that is building on the primary research of the founding academics to develop novel treatments for disease by controlling the activity of hypoxia inducible factor (HIF).
Incorporated in May 2003
Origin: Oxford University, Department of Physiology, Anatomy and Genetics